Factor VIII products and inhibitor development: concepts for revision of European regulatory guidelines.
Neugebauer
B
B
Drai
C
C
Haase
M
M
Hilger
A
A
Keller-Stanislawski
B
B
Laitinen-Parkkonen
P
P
Mentzer
D
D
Rasmussen
C
C
Ratignier
C
C
Seitz
R
R
D002985:Clinical Protocols / Q000592:standards; D002986:Clinical Trials as Topic / Q000592:standards; D005169:Factor VIII / Q000276:immunology* / Q000627:therapeutic use*; D006801:Humans; D007518:Isoantibodies / Q000097:blood; D017410:Practice Guidelines as Topic / Q000592:standards*
D007518:Isoantibodies; D005169:Factor VIII